Lv714
4080 积分 2021-02-01 加入
Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity
42分钟前
待确认
Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing
3小时前
求助中
Negative Regulation of Immunoreceptor Signaling
6小时前
求助中
Using TCR-CAR dual signaling for precise cancer targeting
6小时前
已完结
Positive longer-term results for efruxifermin in MASH
2天前
求助中
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
2天前
已完结
“Beyond CAR-T: Engineered NK Cell Therapies (CAR-NK, NKCEs) in Next-Generation Cancer Immunotherapy”
8天前
已完结
GRP78: A New Promising Candidate in Colorectal Cancer Pathogenesis and Therapy
26天前
已完结
Aberrant engagement of P-selectin drives hematopoietic stem cell aging in mice
30天前
已关闭
Supercharging CAR-T cells through transcriptional and epigenetic armoring
1个月前
已完结
皖公网安备34019202002308
